BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21470627)

  • 1. Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerism.
    Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Okada S; Kanamoto A; Takayama T
    J Surg Res; 2012 Jun; 175(1):62-6. PubMed ID: 21470627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
    Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Kanamoto A; Okada S; Takayama T
    J Surg Res; 2012 Nov; 178(1):133-8. PubMed ID: 22502904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenocytes can replace chimeric cells and maintain allograft tolerance.
    Hayashi Y; Yamazaki S; Kanamoto A; Takayama T
    Transplantation; 2007 Nov; 84(9):1168-73. PubMed ID: 17998873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance.
    Deng W; Han Q; Liao L; Li C; Ge W; Zhao Z; You S; Deng H; Zhao RC
    Exp Hematol; 2004 Sep; 32(9):861-7. PubMed ID: 15345288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; OnoƩ K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
    J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
    Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
    Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
    Leshem B; Tsuberi BZ; Lebendiker Z; Anafi-Ayalon M; Shalit M; Weiss L; Slavin S; Kedar E
    Transplantation; 1987 Jun; 43(6):814-7. PubMed ID: 2954282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.